A previous study demonstrated that the FABP4 levels ae higher in NSCLC tissues than in normal tissues and that these high FABP4 levels have an unfavorable impact on the OS of NSCLC patients. The gene discussed is FABP4; the disease is non-small cell lung carcinoma.